GlassScriptPhysician profile
Danielle Kathleen Thrower
NPI 1457321366
$1,293.94
in general payments reported to CMS, 2019-2025
17 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $196 · 2023: $297 · 2024: $392 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $228.35 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $183.76 | 2023-2024 | Reblozyl |
| Abbvie INC. | $180.25 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2024 | Iclusig |
| Kite Pharma, INC. | $124.46 | 2025 | Yescarta |
| Jazz Pharmaceuticals INC. | $103.29 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $72.20 | 2022 | |
| Alexion Pharmaceuticals, INC. | $52.22 | 2024-2025 | Ultomiris |
| Astellas Pharma US INC | $42.43 | 2025 | Xospata |
| Genmab U.S., INC. | $31.73 | 2025 | Tivdak |
| Adaptive Biotechnologies Corporation | $28.98 | 2025 | Clonoseq |
| Janssen Biotech, INC. | $24.17 | 2025 | Carvykti |
| Pfizer INC. | $22.01 | 2024 | |
| Genentech USA, INC. | $20.46 | 2025 | Venclexta |
| Stemline Therapeutics INC. | $19.92 | 2025 | Orserdu |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $19.60 | 2025 | Rezlidhia, Gavreto, Tavalisse |
| Merck Sharp & Dohme LLC | $15.11 | 2025 | Prevymis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Thrower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.